232 related articles for article (PubMed ID: 17451569)
1. Oral budesonide in the treatment of chronic refractory pouchitis.
Gionchetti P; Rizzello F; Poggioli G; Pierangeli F; Laureti S; Morselli C; Tambasco R; Calabrese C; Campieri M
Aliment Pharmacol Ther; 2007 May; 25(10):1231-6. PubMed ID: 17451569
[TBL] [Abstract][Full Text] [Related]
2. Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis.
Shen B; Fazio VW; Remzi FH; Bennett AE; Lopez R; Brzezinski A; Oikonomou I; Sherman KK; Lashner BA
Dis Colon Rectum; 2007 Apr; 50(4):498-508. PubMed ID: 17279300
[TBL] [Abstract][Full Text] [Related]
3. High-dose probiotics for the treatment of active pouchitis.
Gionchetti P; Rizzello F; Morselli C; Poggioli G; Tambasco R; Calabrese C; Brigidi P; Vitali B; Straforini G; Campieri M
Dis Colon Rectum; 2007 Dec; 50(12):2075-82; discussion 2082-4. PubMed ID: 17934776
[TBL] [Abstract][Full Text] [Related]
4. Oral beclomethasone dipropionate in chronic refractory pouchitis.
Gionchetti P; Calabrese C; Calafiore A; Praticò C; Poggioli G; Laureti S; Capozzi N; Campieri M; Rizzello F
J Crohns Colitis; 2014 Jul; 8(7):649-53. PubMed ID: 24394806
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis.
Shen B; Pardi DS; Bennett AE; Queener E; Kammer P; Hammel JP; LaPlaca C; Harris MS
Am J Gastroenterol; 2009 Jun; 104(6):1468-74. PubMed ID: 19436282
[TBL] [Abstract][Full Text] [Related]
6. Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice.
Shen B; Brzezinski A; Fazio VW; Remzi FH; Achkar JP; Bennett AE; Sherman K; Lashner BA
Aliment Pharmacol Ther; 2005 Oct; 22(8):721-8. PubMed ID: 16197493
[TBL] [Abstract][Full Text] [Related]
7. Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis.
Calabrese C; Fabbri A; Gionchetti P; Rizzello F; Morselli C; Liguori G; Poggioli G; Campieri M; Di Febo G
Aliment Pharmacol Ther; 2007 Jun; 25(11):1311-6. PubMed ID: 17509099
[TBL] [Abstract][Full Text] [Related]
8. Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Gosselink MP; Schouten WR; van Lieshout LM; Hop WC; Laman JD; Ruseler-van Embden JG
Dis Colon Rectum; 2004 Sep; 47(9):1519-25. PubMed ID: 15486751
[TBL] [Abstract][Full Text] [Related]
9. [Oral budesonide in the treatment of chronic refractory pouchitis].
Cabriada Nuño JL; Hernández Martín A; Bernal Martínez A; Zabalza Estévez I
Gastroenterol Hepatol; 2008 Oct; 31(8):485-9. PubMed ID: 18928746
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment with infliximab in chronic refractory pouchitis and ileitis.
Calabrese C; Gionchetti P; Rizzello F; Liguori G; Gabusi V; Tambasco R; Poggioli G; Pierangeli F; Campieri M; Di Febo G
Aliment Pharmacol Ther; 2008 May; 27(9):759-64. PubMed ID: 18298639
[TBL] [Abstract][Full Text] [Related]
11. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis.
Mimura T; Rizzello F; Helwig U; Poggioli G; Schreiber S; Talbot IC; Nicholls RJ; Gionchetti P; Campieri M; Kamm MA
Aliment Pharmacol Ther; 2002 May; 16(5):909-17. PubMed ID: 11966499
[TBL] [Abstract][Full Text] [Related]
12. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial.
Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M
Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826
[TBL] [Abstract][Full Text] [Related]
13. Management of refractory fistulizing pouchitis with infliximab.
Viscido A; Kohn A; Papi C; Caprilli R
Eur Rev Med Pharmacol Sci; 2004; 8(5):239-46. PubMed ID: 15638238
[TBL] [Abstract][Full Text] [Related]
14. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
[TBL] [Abstract][Full Text] [Related]
15. Rifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.
Abdelrazeq AS; Kelly SM; Lund JN; Leveson SH
Colorectal Dis; 2005 Mar; 7(2):182-6. PubMed ID: 15720360
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of ileal pouch polyps in patients with underlying ulcerative colitis.
Schaus BJ; Fazio VW; Remzi FH; Bennett AE; Lashner BA; Shen B
Dis Colon Rectum; 2007 Jun; 50(6):832-8. PubMed ID: 17309000
[TBL] [Abstract][Full Text] [Related]
17. Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review.
Hoda KM; Collins JF; Knigge KL; Deveney KE
Dis Colon Rectum; 2008 May; 51(5):554-60. PubMed ID: 18266037
[TBL] [Abstract][Full Text] [Related]
18. Pilot study: the use of sulfasalazine for the treatment of acute pouchitis.
Belluzzi A; Serrani M; Roda G; Bianchi ML; Castellani L; Grazia M; Rosati G; Ugolini G; Roda E
Aliment Pharmacol Ther; 2010 Jan; 31(2):228-32. PubMed ID: 19817724
[TBL] [Abstract][Full Text] [Related]
19. Controlled, open, randomized multicenter trial comparing the effects of treatment on quality of life, safety and efficacy of budesonide foam and betamethasone enemas in patients with active distal ulcerative colitis.
Hammond A; Andus T; Gierend M; Ecker KW; Scholmerich J; Herfarth H;
Hepatogastroenterology; 2004; 51(59):1345-9. PubMed ID: 15362749
[TBL] [Abstract][Full Text] [Related]
20. Topical tacrolimus therapy for antibiotic-refractory pouchitis.
Uchino M; Ikeuchi H; Matsuoka H; Bando T; Hida N; Nakamura S; Takesue Y; Tomita N
Dis Colon Rectum; 2013 Oct; 56(10):1166-73. PubMed ID: 24022534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
